Vitamin D as a risk factor for premature atherosclerosis in patients with type 2 diabetes

Therapeutic Advances in Endocrinology and Metabolism

Volumn 6, Issue 6, 2015, Pages 249-257

  Al Said, Nehal Hamdy ^a   Mohamed, Nagwa Abd El Ghaffar ^b   Salam, Randa F ^a   Fawzy, Mary Wadie ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

atherosclerosis; diabetes; vitamin D

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

EID: 84947441965     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018815600640     Document Type: Article

References (31)

1. Alexander C. Landsman P. Teutsch S. Haffner S. Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program. (2003) NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52: 1210–1214.
2. Allison M. His S. Wassel C. Morgan C. Joachim H. Wright C. et al. (2012) Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol 32: 140–146.
3. Brewer L. Michos E. Reis J. (2011) Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 12: 54–60.
4. Emmen J. Wielders J. Boer A. van den Ouweland J. Vader H. (2012) The new Roche vitamin D total assay: fit for its purpose? Clin Chem Lab Med 8: 1–4.
5. Friedewald W. Levy R. Fredrickson D. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499–502.
6. Hajas A. Sandor J. Csathy L. Csipo I. Barath S. Paragh G. et al. (2011) Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 10: 317–324.
7. Haussler M. Jurutka P. Mizwicki M. (2011) Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25: 543–559.
8. Jashari F. Ibrahimi R. Nicoll G. Bajraktari G. Wester P. Henein M. (2013) Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis 227: 193–200.
9. Kamycheva E. Johnsen S. Wilsgaard T. Jorde R. Mathiesen E. (2013) Evaluation of serum 25-hydroxyvitamin D as a predictor of carotid intima-media thickness and carotid total plaque area in nonsmokers: the Tromsø Study. Int J Endocrinol 2013: 305141.
10. Melamed M. Muntner P. Michos E. Uribarri J. Weber C. Sharma J. et al. (2008) Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28: 1179–1185.
11. Merke J. Milde P. Lewicka S. Hügel U. Klaus G. Mangelsdorf D. et al. (1989) Identification and regulation of 1,25-dihydroxyvitamin D 3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83: 1903–1915.
12. Michos E. Streeten E. Ryan K. Rampersaud E. Peyser P. Bielak L. et al. (2009) Serum 25- hydroxyvitamin D levels are not associated with subclinical vascular disease or C-reactive protein in the old order Amish. Calcif Tissue Int 84: 195–202.
13. O'Leary D. Polak J. (2002) Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90: 18–21.
14. Pearce S. Cheetham T. (2010) Diagnosis and management of vitamin D deficiency. Br Med J 340: b5664.
15. Perez-Fontan M. Cordido F. Rodriguez-Carmona A. Peteiro J. Garcia-Naveiro R. Garcia-Buela J. (2004) Plasma ghrelin in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19: 2095–2100.
16. Pilz S. Henry R. Snijder M. Nijpels G. Dam R. Stehouwer C. (2009) 25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women. Calcif Tissue Int 84: 423–424.
17. Reilly M. Rader D. (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108: 1546–1551.
18. Reis J. von Mühlen D. Michos E. Miller E. Lawrence J. Appel L. et al. (2009) Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 207: 585–590.
19. Richart T. Thijs L. Nawrot T. Yu J. Kuznetsova T. Balkestein E. et al. (2011) The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D3 ratio in a general population. Am J Hypertens 24: 102–109.
20. Ross A. Judd S. Kumari M. Hileman C. Storer N. Labbato D. et al. (2011) Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther 16: 555–563.
21. Scragg R. Sowers M. Bell C. (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813–2818.
22. Shikuma C. Seto T. Liang C. Bennett K. DeGruttola V. Gerschenson M. et al. (2012) Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses 28: 793–797.
23. Sypniewska G. Pollak J. Strozecki P. Camil F. Kretowicz M. Janikowski G. et al. (2014) 25-hydroxyvitamin D, biomarkers of endothelial dysfunction and subclinical organ damage in adults with hypertension. Am J Hypertens 27: 114–121.
24. Targher G. Bertolini L. Padovani R. Zenari L. Scala L. Cigolini M. et al. (2006) Serum 25-hydroxyvitamin D 3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 65: 593–597.
25. Touboul P. Grobbee D. Ruijter H. (2012) Assessment of subclinical atherosclerosis by carotid intima media thickness: technical issues. Eur J Prev Cardiol 19: 8–24.
26. Vanhoutte P. (1997) Endothelial dysfunction and atherosclerosis. Eur Heart J 18(Suppl. E): E19–E29.
27. Vanhoutte P. Feletou M. Taddei S. (2005) Endothelium-dependent contractions in hypertension. Br J Pharmacol 144: 449–458.
28. Wallace T. Levy J. Matthews D. (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487–1495.
29. Wang T. Pencina M. Booth S. Jacques P. Ingelsson E. Lanier K. et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503e11.
30. Wong M. Delansorne R. Man R. (2008) Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 295: H289–H296.
31. Zehnder D. Bland R. Chana R. (2002) Synthesis of 1,25-dihydroxyvitamin D (3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13: 621–629.